FDA review OKs Cornerstone drug for low salt condition, not heart failure patients MedCity News However, she said the drug should not be approved for heart failure patients, which the company had also sought. The FDA staff review comes ahead of an advisory panel of outside experts, which will vote on whether to recommend the drug on Thursday. FDA review backs Cornerstone drug for low salt FDA review backs Cornerstone's new heart drug – with a hitch Cornerstone Therapeutics Entering A Decisive Week |
